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Abstract
Buruli ulcer (BU) is a disabling and stigmatising neglected tropical disease (NTD). Its distri-
bution and burden are unknown because of underdiagnosis and underreporting. It is caused
by Mycobacterium ulcerans, an environmental pathogen whose environmental niche and
transmission routes are not fully understood. The main control strategy is active surveillance
to promote early treatment and thus limit morbidity, but these activities are mostly restricted
to well-known endemic areas. A better understanding of environmental suitability for the
bacterium and disease could inform targeted surveillance, and advance understanding of
the ecology and burden of BU. We used previously compiled point-level datasets of BU and
M. ulcerans occurrence, evidence for BU occurrence within national and sub-national areas,
and a suite of relevant environmental covariates in a distribution modelling framework. We
fitted relationships between BU and M. ulcerans occurrence and environmental predictors
by applying regression and machine learning based algorithms, combined in an ensemble
model to characterise the optimal ecological niche for the disease and bacterium across
Africa at a resolution of 5km x 5km. Proximity to waterbodies was the strongest predictor of
suitability for BU, followed potential evapotranspiration. The strongest predictors of suitabil-
ity for M. ulcerans were deforestation and potential evapotranspiration. We identified patchy
foci of suitability throughout West and Central Africa, including areas with no previous evi-
dence of the disease. Predicted suitability for M. ulcerans was wider but overlapping with
that of BU. The estimated population living in areas predicted suitable for the bacterium and
disease was 46.1 million.
These maps could be used to inform burden estimations and case searches which would
generate a more complete understanding of the spatial distribution of BU in Africa, and may
guide control programmes to identify cases beyond the well-known endemic areas.
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Like many neglected tropical diseases primarily affecting the rural poor, Buruli ulcer (BU)
is under-detected and under-reported within routine health information systems. As
such, the burden and distribution are not fully known, impeding appropriate targeting of
health resources, control, and care for people affected. Having previously evaluated and
mapped the existing evidence for BU and its causative agent M. ulcerans, we concluded
that the disease was likely to occur beyond the range of known endemic areas. However,
we were left with the question of where exactly these undetected cases might be occurring.
Answering this question required a more fine-scale approach: BU is highly focal, presum-
ably due to local variation in the environmental factors which determine suitability for M.
ulcerans survival and transmission to humans. We used the compiled evidence and geo-
graphical datasets to build statistical models representing the relationship between envi-
ronmental factors and previously reported cases. This allowed us to define the ecological
niche of BU, and subsequently to identify areas across Africa where this niche was met,
providing suitable conditions for the disease. We constructed separate models of suitabil-
ity for M. ulcerans, using locations where its DNA had been detected in environmental
sources. Unsurprisingly, suitability for M. ulcerans was predicted to be wider than, but
geographically overlapping with that for BU. This implies that beyond the conditions nec-
essary for survival of the bacterium, additional factors are required for transmission to
humans. The high-resolution suitability maps we present are intended to guide case
search activities which may identify endemic areas beyond the known endemic range.
Data on the true prevalence of BU from targeted case searches within predicted-suitable
areas will also allow us to validate and refine the models, and potentially to predict the
probability of cases occurring within predicted suitable areas.
Introduction
Buruli ulcer (BU) is a chronic necrotizing disease of the skin and soft tissue, which causes
debilitating symptoms and sequelae, associated with a high burden of morbidity and stigma
for patients and economic costs for affected households [1–3]. These impacts are felt particu-
larly strongly in impoverished rural communities with poor access to health services [3,4]. The
infectious agent is Mycobacterium ulcerans, a slow-growing environmental bacterium which
appears to be transmitted from aquatic environments to humans by penetration of the skin,
although the exact pathways are not fully understood and are likely to be diverse [1,5,6]. The
main control strategy is active case finding in endemic areas to promote early case detection
and effective treatment, which limits disease progression [7,8]. BU occurs mostly in tropical
and subtropical areas of West and Central Africa, with smaller foci in parts of Asia, South
America, the Western Pacific and Australasia [9]. However, the disease is recognised to be
underdiagnosed and under-reported, and may occur undetected in other parts of the world
[9–12].
In the 1950’s and 60’s, large numbers of cases occurred in Nakasongola District in Uganda,
but the incidence of disease in this area then declined and has apparently not resurged since
(S1 and S2 Figs) [13]. In West Africa, the highest incidence was reported in the mid 1990’s and
appears to have been declining since 2008 [13]. The distribution of BU is presumably linked to
environmental suitability- the availability of appropriate conditions- for M. ulcerans survival
and replication, as well as to human and environmental factors favouring transmission [14].
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On a continental scale, BU appears to be limited by climatic factors: it is mostly restricted to
tropical and subtropical regions and is absent from arid areas [15]. Within endemic areas, the
disease shows a highly focal distribution [16–18], but reasons for this are not well understood,
since the precise niche and transmission routes of M. ulcerans have been difficult to character-
ise [19]. The pathogen has only been cultured from environmental and animal samples a hand-
ful of times [20–22], although it has been detected by PCR in aquatic environments of
endemic and non-endemic areas, and in a wide range of potential hosts including mammals,
fish, amphibians, and aquatic and terrestrial insects [23–27]. Consistent with the ecology of an
environmental pathogen, the distribution of M. ulcerans in the environment appears to be
wider than that of BU, suggesting that factors beyond environmental suitability for M. ulcerans
are required for transmission [14,15,28].
Our understanding of the pathways of BU infection is also limited, partly by its long and
variable incubation period, which makes it difficult for patients and clinicians to attribute par-
ticular events or activities to disease acquisition [29]. Local spatial analysis has identified sev-
eral environmental variables associated with increased BU incidence, primarily proximity to
rivers, as well as environmental disturbance and land-use changes including deforestation,
urbanisation, agriculturalization, damming of rivers and mining [30,31]. Case control studies
have identified contact with unprotected waterbodies as a risk factor for disease [32], suggest-
ing that activities which bring people into contact with water sources harbouring M. ulcerans
increase the risk of disease acquisition [33–35].
Given the recognised scale of BU under-detection and under-reporting, it is likely that the
disease occurs beyond the known range of reported cases. A better understanding of potential
suitability for the pathogen in the environment and the disease in humans would help to
improve its surveillance and control in countries where is known to be endemic. Furthermore,
characterisation of the environmental factors linked to suitability for M. ulcerans and BU may
reveal areas at risk of disease emergence, or harbouring unrecognised cases.
In this investigation, we aim to identify environmental factors which characterise the envi-
ronmental niche of M. ulcerans and BU disease in humans, and to model their respective rela-
tionships with M. ulcerans and BU occurrence. These analyses will be used to identify areas of
continental Africa which may be suitable for M. ulcerans or BU based on their environmental
characteristics.
Methods
Data on Buruli ulcer and M. ulcerans distribution
We used previously compiled datasets of point locations of recorded occurrences of BU disease
in humans, and of detection of M. ulcerans genetic material in biotic and abiotic environmen-
tal samples [9,36]. The datasets were compiled through a systematic review [9] and the BU
dataset was supplemented with surveillance data from BU control programmes in Ghana,
Nigeria and Cameroon. The literature search was updated in October 2020.
BU occurrence locations were restricted to those where BU infection was confirmed by a
positive result for PCR targeting IS2404, or histopathology consistent with BU disease. To
explore the model’s sensitivity to the case definition, we repeated the analysis using all loca-
tions where clinically diagnosed BU had been reported. We hereon refer to the two datasets as
‘confirmed occurrences’ and ‘all occurrences’ respectively.
The environmental dataset was restricted to locations where M. ulcerans DNA had been
identified and distinguished from that of other mycobacteria: either by multiplex qPCR assays
quantifying the relative copy numbers of IS2404, IS2606 and the KR-B domain [37]; by
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variable nucleotide tandem repeat (VNTR); or mycobacterial interspersed repetitive unit
(MIRU) typing [38,39]. We hereon refer to this dataset as ‘environmental occurrences’.
All records were restricted to locations with reliable geographical coordinates and dedupli-
cated by geographical location.
Environmental datasets used in ecological modelling
We assembled gridded datasets of 14 environmental variables considered relevant to the eco-
logical niche of the bacterium or disease [19]. These included four variables considered to
characterise the tropical and subtropical biomes from where the majority of BU cases in Africa
have been reported [40]: minimum and maximum temperature [41,42], the aridity index,
quantifying atmospheric aridity (the balance of precipitation and atmospheric water demand
[43,44]) and potential evapo-transpiration (a measure of atmospheric capacity to remove
water from the air through evaporation and transpiration assuming unlimited water availabil-
ity) [40,43]. Tropical climates are also characterised by the amount of precipitation they expe-
rience, so we included indicators of precipitation seasonality and precipitation in the wettest
and driest quarters [45], which have been linked to trends in the abundance of M. ulcerans in
the environment and the incidence of BU cases in Cameroon, Ghana, and Uganda [46–48].
We also included indicators of topography which may identify the swampy, stagnant environ-
ments where BU is often reported in endemic countries [14,49], specifically elevation [43] and
topological wetness index (derived from elevation), representing the potential for each cell to
accumulate water based on its elevation relative to surrounding cells and the potential for
drainage [50]. Since particular vegetation and landcover types have previously been associated
with BU endemicity [31,49], we included the enhanced vegetation index (EVI) which quanti-
fies vegetation cover [51,52]. We calculated Euclidean (straight line) to the nearest river or
stream, and to the nearest waterbody recorded on Open Street Map, as contact with unpro-
tected water is a known risk factor for BU [32,53]. Finally, we included a range of human-
driven factors which have been associated with BU emergence and transmission: deforestation
[54,55], agriculturalization [2,55] and damming of rivers [13,55,56,57]. We calculated Euclid-
ean (straight line) to the nearest area of deforested land and the nearest agricultural area using
landcover data [58], and to the nearest dam recorded on Open Street Map [53]. Full details of
all variables and their sources are provided in S2 Text.
Variable selection
We compiled the gridded candidate predictors at a resolution of 5km x 5km within a rectangu-
lar area of West Africa from latitude -13.57195, longitude -4.11032, to lat. 16.67107, long.
14.493. This area contained 94% of all BU occurrence locations, 95% of confirmed BU occur-
rence locations, and all environmental occurrence locations. We extracted the values of predic-
tor variables at the locations of BU cases (all occurrences) and environmental occurrences of
M. ulcerans DNA. We calculated the covariance between all candidate predictors and dropped
those which were correlated with another variable with a Pearson correlation coefficient of
above 0.8 (or below -0.8), retaining the variable with the strongest existing evidence or biologi-
cal plausibility for an association with BU or M. ulcerans distribution or suitability.
Pseudoabsence and background data
One major challenge in species distribution modelling is the scarcity of data on locations
absent for the species or disease of interest, since absence from a given area is difficult to estab-
lish with certainty [59]. To account for this, we generated pseudo-absence points, representing
the comparator class for the models, in areas where BU was assumed to be absent [60]. We
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used the surface range envelope function within the biomod2 package in R [61] to identify
areas presumably suitable for the disease (containing values between the 2.5th and 97.5th per-
centiles of the selected predictor variables) and sampled pseudoabsence points from outside of
this envelope. The selection of pseudoabsences was biased to areas with lower evidence of BU
endemicity, using data from a systematic review of the geographical distribution of BU [9] to
ensure higher coverage of pseudoabsence points in countries with lower evidence for BU. Fur-
ther details are given in S1 Text.
Another challenge in species distribution modelling is that data from surveys and passive
surveillance are often geographically biased due to variation in data collection intensity, which
can lead to erroneous predictions if this bias is not accounted for [62]. We generated a separate
class of model negative points which we refer to as background points. We distinguish back-
ground points from pseudoabsence points on the basis that we make no assumption about the
occurrence of or suitability for BU or M. ulcerans at the background locations [60], and simply
use these points to balance out the spatial bias in the occurrence points. This process has previ-
ously been termed ‘background thickening’ [63]. Background points were sampled at higher
density around recorded occurrence points. More details are provided in S1 Text.
Human background and pseudoabsence points were restricted to a minimum distance of
10km from any BU occurrence location, and environmental background and pseudoabsence
points were restricted to 10km from any environmental occurrence location. Within the mod-
els, pseudoabsence and background points were downweighted by 50% compared to occur-
rence points. The distributions of pseudoabsence and background points for the Buruli ulcer
suitability models are shown in S3 and S4 Figs and those for the M. ulcerans suitability models
in S5 and S6 Figs.
Ensemble modelling
The selected environmental covariates were used as predictor variables and the occurrence,
pseudoabsence and background locations were included as the outcome. We used the biomod2
package in R [61,64] to implement seven algorithms: generalized linear models (GLM), gener-
alized additive models (GAM), generalized boosted regression models (GBM), artificial neural
networks (ANN), multiple adaptive regression splines (MARS), maximum entropy (MaxEnt)
and random forest (RF).
Individual model algorithms were each run 20 times with a random sample of 80% of data
points, and evaluated with the remaining 20%. For each algorithm we calculated the mean true
skill statistic (TSS), the mean percent correctly classified (PCC) and the mean area under the
curve (AUC) of the receiver operation characteristic (ROC) [65]. The TSS is a prevalence-inde-
pendent measure of predictive accuracy, calculated as sensitivity + specificity– 1 and ranging
from -1 to 1 with a score of 1 representing perfect agreement between model predictions and
data, and values from 0 to -1 representing performance no better than random. The PCC is a
measure of accuracy, calculated as the proportion of points that were correctly classified. The
AUC is another measure of model accuracy, measured from 0 to 1 with high values indicating
better differentiation of positive and negative values. The AUC is calculated as the area under
the curve of the ROC- a plot showing the true positive rate on the y-axis and the false positive
rate on the x-axis.
Models with mean AUC above 0.8 were integrated in an ensemble using committee averag-
ing to attribute higher weight to better performing models.
We plotted the importance values representing the contribution of each variable to the
model and created marginal effect plots for the modelled covariates in the highest performing
model ensemble.
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Estimating total population living in suitable areas
We calculated the total area suitable for BU, M. ulcerans, and the total area suitable for both,
and extracted estimates of the population living in each of these areas from a raster (gridded)
dataset representing estimated number of people per 1km2 grid square in 2020 [66].
Results
Datasets of BU occurrence in humans and M. ulcerans DNA detection in
the environment
The modelled data included 3,700 unique point locations with reported cases of BU in Africa
(Fig 1A). BU was confirmed by PCR or histopathology at 1,041 unique locations (Fig 1A).
There were 79 unique locations where M. ulcerans DNA had been detected by MIRU, VNTR
or qPCR (Fig 1B).
The dataset of clinically diagnosed human cases represented 16 countries, mostly in West
and Central Africa, with a few in East and southeast Africa. The confirmed cases were
restricted to 12 countries in Africa. The distribution of modelled occurrence points is shown
in Fig 2. The time period of human case detection was from 1957 to 2019. The median year of
diagnosis was 2010. The 91 records of environmental detection of M. ulcerans represented
four countries: Ghana, Cameroon, Benin and Togo, and covered the period from 2006 to 2018
with a median year of detection of 2013.
Environmental covariates
Maximum temperature and elevation were excluded from the framework for BU modelling as
they were collinear with minimum temperature. The aridity index was dropped as it was colin-
ear with precipitation in the wettest quarter. The topographic wetness index was excluded
after the initial modelling step as it made a very limited contribution to the models. The model
predictors were therefore annual potential evapotranspiration, minimum temperature, precip-
itation seasonality, precipitation in the wettest quarter, precipitation in the driest quarter,
enhanced vegetation index and distances to rivers and streams, water bodies, dams, deforested
areas, and agricultural land.
Maximum temperature, elevation and aridity index were also dropped from the M. ulcerans
modelling framework due to collinearity with minimum temperature. Precipitation seasonal-
ity was dropped due to collinearity with precipitation in the driest quarter, and precipitation
Fig 1. Selection of model occurrence points from Buruli ulcer database. Selection is shown separately for Buruli
ulcer occurrences (A) and environmental occurrences of Mycobacterium ulcerans DNA.
https://doi.org/10.1371/journal.pntd.0009157.g001
PLOS NEGLECTED TROPICAL DISEASES Mapping fine-scale suitability for Buruli ulcer in Africa
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009157 March 3, 2021 6 / 21
Fig 2. Distribution of occurrence records for environmental modelling of Burli ulcer (BU) and Mycobacterium ulcerans (MU) (A) Pink dots
represent origins of clinically-diagnosed BU cases, red dots represent confirmed cases. (B) Red dots show locations where M. ulcerans DNA has
PLOS NEGLECTED TROPICAL DISEASES Mapping fine-scale suitability for Buruli ulcer in Africa
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009157 March 3, 2021 7 / 21
in the wettest quarter was dropped due to collinearity with minimum temperature. The model
predictors were annual potential evapotranspiration, minimum temperature, precipitation in
the wettest quarter, enhanced vegetation index, topographic wetness index and distances to
rivers and streams, water bodies, dams, deforested areas, and agricultural land.
Environmental suitability for BU
The overall predicted distribution was constrained to humid tropical areas and local scale vari-
ation appeared to be driven by hydrological features (Fig 3A). The total area predicted to be
suitable for BU was 373,625 km2, and the total population living in areas predicted suitable
was 72.3 million (Table 2). Pockets of suitability for BU were predicted in 19 countries in
Africa, including all 14 countries along the west-central African coastline from Guinea to
Angola (S1 Maps and S1 Table). Democratic Republic of the Congo had the widest area pre-
dicted suitable, followed by Cameroon. Nigeria had the largest population at risk, with 25.4
million predicted to be living in areas suitable for BU, followed by the Democratic Republic of
the Congo where 14.6 million were predicted to be living in suitable areas (S1 Table).
The model including all cases of BU (S7 Fig) gave similar results to the model including
confirmed cases only. The Pearson coefficient of correlation between the two models was over
0.95.
All individual distribution models performed well with AUC values above 0.8 (S8 and S9
Figs). Mean PCC scores were between 77.4 and 92.9% and mean TSS scores were between 0.57
and 0.83. RF models performed best with a mean PCC of 92.9%, a mean TSS of 0.83 and mean
AUC 0.97. The final ensemble model showed an overall mean AUC of 0.96 with sensitivity of
91.0% and specificity of 88.7%. The mean TSS was 0.79 and the mean kappa score was 0.80
(Table 1).
Distance to the nearest water body was the strongest contributor to the RF models, explain-
ing 23.8% of variance in the model, followed by potential evapotranspiration, which contrib-
uted 19.3% of the variance (S10 Fig). Suitability for BU was highest in areas within 10km of the
nearest waterbody, and was limited in areas more than 30km from a waterbody (S11 Fig). Suit-
ability was highest in environments with relatively low potential evapotranspiration (1,200–
1,600 mm/month), which correlates with the tropical savanna climate zone [67,68].
Environmental suitability for M. ulcerans
The GAM, GBM, MARS and RF models performed well with AUC above 0.8 (S12 and S13
Figs), while the GLM, ANN and MAXENT Phillips models performed less well and were
excluded from the ensemble. Mean PCC varied from 0.72–0.83 between models and mean
TSS was between 0.34 and 0.66. RF outperformed other algorithms in predicting the occur-
rence of M. ulcerans. The final ensemble model had a mean TSS score of 0.87, with a sensitivity
of 92.4 and specificity of 94.4% (Table 1). The mean AUC was 0.98 and the mean kappa score
was 0.87.
Distance to deforested areas and potential evapotranspiration were the strongest predictors
of M. ulcerans occurrence in the RF models, accounting for 28.4% and 28.2% of all variance in
the model respectively (S14 Fig). Suitability was predicted to be low in areas more than 30km
from any deforested land, and in areas with potential evapotranspiration of>1500mm/month
been isolated from environmental samples and distinguished from DNA from other mycobacteria by multiplex qPCR, or by variable nucleotide
tandem repeat, or mycobacterial interspersed repetitive unit typing. All maps were produced in ArcMap 10.7 (ESRI Inc., Redlands CA, USA).
https://doi.org/10.1371/journal.pntd.0009157.g002
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(corresponding to more humid regions characterised by higher rainfall and semi-deciduous to
tropical forest) (S15 Fig).
The total area predicted to be suitable for M. ulcerans was 388,050km2, and the total popula-
tion living in areas predicted suitable was 77.0 million (Table 2). Pockets of suitability were
predicted in 17 countries (S1 Table). Nigeria had the widest area predicted suitable
(85,350km2) followed by Cameroon (66,300km2). The highest population living in suitable
areas was in Nigeria (33.1 million).
Overlap of suitability for BU and M. ulcerans
The total area predicted to be suitable for both BU and M. ulcerans was 163,225km2, with 46.1
million people predicted to be living in areas at risk. There were some differences in the extents
of the areas predicted suitable for BU disease and environmental M. ulcerans (Fig 4). There
were wide areas predicted suitable for M. ulcerans but not for BU disease, mostly located
around the periphery of known endemic foci in west African countries. There were patches of
predicted suitability for BU but not M. ulcerans in DRC, Sierra Leone, Liberia and other coun-
tries in West Africa. The highest populations living in areas predicted suitable for both BU and
M. ulcerans were in Nigeria and DRC, with 18.0 and 10.1 million respectively at risk.
Discussion
We have used ecological niche modelling to identify environmental factors associated with the
occurrence of Buruli ulcer and its causative agent M. ulcerans, and to predict environmental
suitability for the disease and bacterium across continental Africa. Incorporating existing data
on BU distribution at multiple spatial levels and a set of relevant environmental covariates, the
resulting maps represent evidence-based predictions which are intended to guide future sur-
veillance for BU.
The model predictions were broadly consistent with the recognised distribution of BU in
Africa [9]. We identified pockets of suitability for BU in patchy foci throughout the known-
endemic range of the disease, particularly in the tropical zones of countries around the Gulf of
Guinea. Suitability was also predicted in a number of regions not previously recognised as
endemic, particularly in Sierra Leone, the north-west coast of Liberia, and parts of southern
Nigeria. Wide areas of suitability were predicted beyond the known foci of BU in DRC, partic-
ularly along the Kasai river basin in the central-west region of the country. In Gabon, an
extended focus of suitability was predicted towards the mouth of the Ogooue River. Several
cases of BU have been reported from this area [69], but were not included in the main model
presented here as they were not confirmed by PCR or histopathological analysis. A further
Fig 3. A.) Predicted environmental suitability for the occurrence of BU disease and associated error of prediction. B.) Predicted environmental suitability for the
occurrence of M. ulcerans in the environment and associated error of prediction. All maps were produced in ArcMap 10.7 (ESRI Inc., Redlands CA, USA).
https://doi.org/10.1371/journal.pntd.0009157.g003
Table 1. Validation metrics for ensemble models for BU and M. ulcerans suitability.
Mean Lower CI Upper CI
BU suitability TSS 0.783 0.793 0.796
AUC 0.964 0.964 0.965
kappa 0.795 0.788 0.795
MU suitability TSS 0.867 0.867 0.879
AUC 0.983 0.983 0.984
kappa 0.866 0.866 0.873
https://doi.org/10.1371/journal.pntd.0009157.t001
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Gabonese focus was predicted in-land, in the south east of the country, which has no previous
evidence of cases. Restricted foci of suitability were predicted in Equatorial Guinea, corre-
sponding to the origin of cases diagnosed by an expert in BU between 1995 and 2005 [70,71],
although the country has no evidence of cases reported in peer-reviewed literature.
There were also regions predicted unsuitable by the models where empirical evidence sug-
gests previous cases. There are several possible reasons for these discrepancies. Some locations
in northern Cameroon with evidence of PCR-confirmed BU were found to be unsuitable for
the disease. Given the great volume of surveillance data collected by the well-established BU
control programme in Cameroon, some patients are likely to have been diagnosed outside the
region where they acquired the disease [72], and we consider it plausible that some regions
where BU has been recorded are not actually suitable for transmission. The model did not pre-
dict occurrence of BU or M. ulcerans within the early BU foci in Uganda and northern DRC
[46,73–75], or in South Sudan where cases were reported in the early 2000’s [76], although
moderate suitability was predicted around these areas. This discrepancy may indicate that
these foci were associated with transient factors which are no longer locally prevalent, or that
the model lacks sensitivity in areas with sparse occurrence points. The fact that these models
Table 2. Total area predicted suitable and population in areas at risk for Buruli ulcer, M. ulcerans, and both, in Africa.
Total area suitable (km2) Lower bound Upper bound Population in suitable areas Lower bound Upper bound
BU 373,625 283,275 498,550 72,341,372 55,617,280 90,689,787
MU 388,050 265,375 556,225 77,026,709 63,307,468 93,791,018
BU & MU 163,225 104,575 245,675 46,120,259 34,963,000 58,963,221
Suitability for BU and M. ulcerans is shown by country in S1 Maps.
https://doi.org/10.1371/journal.pntd.0009157.t002
Fig 4. Predicted overlap of environmental suitability for BU and of M. ulcerans occurrence. Pink colour represents
areas where Mycobacterium ulcerans (MU) is predicted to occur based on the optimal threshold of environmental
suitability (0.56) but where Buruli ulcer (BU) is not predicted. Red represents areas where BU is predicted based on the
optimal threshold of environmental suitability (0.51) but MU is not. Both BU and MU are predicted to occur in areas
shown in dark red. All maps were produced in ArcMap 10.7 (ESRI Inc., Redlands CA, USA).
https://doi.org/10.1371/journal.pntd.0009157.g004
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do not include a temporal component limits their usefulness for understanding drivers of the
emergence (and disappearance) of BU. Since the number of geo-located confirmed occur-
rences and availability of data on spatial covariates prior to 1991 was limited, we were not able
to stratify the analysis by time period.
Cases of BU have recently been reported in Senegal [77,78] and Madagascar [79], where
occurrence was not predicted by the model. Assuming these recent cases represent true
instances of autochthonous transmission of M. ulcerans, this demonstrates a limitation of
these models in their ability to predict emergent foci in regions that are environmentally dis-
tinct from known-endemic areas. Incorporating new data, particularly those originating from
new-endemic or newly recognised endemic areas, will help to improve the generalisability of
the models in the future.
Although we intend these models to be used as predictive rather than explanatory tools, the
environmental associations we identified have relevance to understanding the ecological niche
and transmission of M. ulcerans. We emphasise that the covariates we included should be
viewed as associated, rather than causal factors. Both BU and M. ulcerans were constrained to
tropical climate zones [68] due to sensitivity to potential evapotranspiration, temperature, and
precipitation indicators. These findings fit with the current understanding of the distribution
of BU in Africa and support evidence for a different epidemiology of the disease in Africa com-
pared to endemic areas of temperate Australia and Japan [80]. Previous evidence suggests that
the strain of M. ulcerans which causes BU in Japan may be adapted to cooler climates [80],
while in Australia there is evidence for an important role of terrestrial mammals [81]. The exis-
tence of mammalian reservoirs may enable the disease to emerge in climates which are unfa-
vourable for maintenance of bacterial populations in the abiotic environment. Importantly,
this does not rule out the possibility of an animal reservoir for BU in [82] Africa [83], since the
range of suitability predicted by these models may illustrate the ecological niche of a different
reservoir taxon.
We identified a number of human-influenced variables as predictors of M. ulcerans occur-
rence, and to a lesser extent, BU occurrence. Variables such as distance to deforested areas,
dams, and agricultural land, and the enhanced vegetation index are expected to show greater
temporal variation than bioclimatic factors, and as such may be more relevant to understand-
ing drivers of change in the distribution of BU. Environmental disturbance has been postu-
lated as a driver of BU emergence [84], and higher rates of disease have been reported in
agricultural areas on the peripheries of forests [85]. Local-scale variation in these factors
resulted in a patchy distribution of predicted suitability, consistent with our understanding of
the epidemiology of BU, which is recognised to be highly focal in endemic settings [86].
Although the models we developed were designed to represent the ecological niche of M.
ulcerans and BU, many aspects of the ecology and transmission of the bacterium were not rep-
resented. The models we developed were ‘black-box’ type representations which risk oversim-
plifying the process of disease transmission as they do not account for ecological complexities
including the behaviour and demography of hosts and interactions between host species [87].
Since these components of BU transmission are currently not well understood, we were lim-
ited to assuming that the observed occurrences of M. ulcerans and BU would adequately repre-
sent the outcomes of these interactions [87]. However, the more general prediction of
suitability has practical applications in informing surveillance efforts, even if it does not enable
precise estimation of transmission risk.
The available dataset of locations where M. ulcerans DNA was detected in the environment
was restricted, including only 79 unique locations in four countries, and cannot be expected to
represent all environmental conditions where the bacterium occurs. The limited coverage of
M. ulcerans data points is a potential source of bias, since the M. ulcerans models may be less
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restrictive than those for BU, potentially explaining the wider predicted occurrence of M.
ulcerans. The scale of analysis (grid cells at 5km x 5km) may have also limited our ability to
quantify the effect of predictors varying over small geographical scales and to capture fine scale
variation in environmental suitability for BU. The models predicted large contiguous areas of
suitability in areas with suitable conditions, particularly in West Africa. Such areas may be
suitable in reality, but exhibit an uneven distribution of disease due to factors not included in
our models.
Despite these limitations, the suitability maps provide a delineation of areas potentially at
risk for BU beyond what is known from the distribution of reported cases, currently the basis
for targeting of surveillance and control. Given the recognised scale of underreporting of BU
[9], the current approach is likely to exclude cases outside of known disease foci, and we sug-
gest that areas predicted suitable for BU and M. ulcerans should be considered as targets for
case finding activities, with the aim of identifying unrecognised foci and patients not known to
the health system. Based on the wide areas of suitability predicted by this work and existing
evidence of under-reporting of BU [88], the south of Nigeria would be a key target for case
finding activities. The foci predicted in Gabon, Equatorial Guinea and Sierra Leone, associated
with limited evidence of previous cases, would also be targets for further investigation. We
note however, that predictions in these regions (not represented by occurrences included in
the model) were associated with high levels uncertainty, which should be considered in the
design of any future surveys.
Using the model predictions to inform the design of cross-sectional surveys for BU could
improve the efficiency of such surveys. In a nationwide survey for podoconiosis in Cameroon,
the selection of survey communities was stratified according predicted suitability for the dis-
ease based on a model trained mainly using data from Ethiopia [89]. This survey identified
higher rates of podoconiosis in communities that were predicted suitable, implying a benefit
in terms of the cost per case identified, compared to a survey employing random selection of
survey communities. Another mechanism to improve cost effectiveness may be to combine
the predictions from these models with models for other diseases in order to target integrated
surveys for rare outcomes [90].
In conclusion, we have identified areas of high suitability for BU and M. ulcerans within
known endemic-areas, and in areas not currently recognised as endemic, but with evidence of
possible undiagnosed or misdiagnosed BU. The population at highest risk of BU is within areas
where BU and M. ulcerans niches overlap, comprising over 46 million people in 2020. The focal
nature of BU distribution, the recognised scale of under-detection, and the impact of late diag-
nosis on disease severity strongly suggest a targeted approach to active case finding as a means
to control this disease. The fine-scale, evidence-based predictions presented here could provide
a tool to target such efforts, which will improve our understanding of the burden and distribu-
tion of the disease and help to increase the proportion of cases linked to treatment.
Supporting information
S1 Maps. Predicted environmental suitability for the occurrence of BU disease and M.
ulcerans in the environment, in countries predicted to be suitable.
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S1 Text. Selection of background and pseudoabsence points.
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S2 Text. Environmental variables used in modelling, including potential environmental
predictors and their sources and the covariates that were included in the models of BU and
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M. ulcerans suitability.
(DOCX)
S1 Fig. Distribution of PCR and histopathologically confirmed BU cases, by year of diag-
nosis.
(TIF)
S2 Fig. Distribution of clinically diagnosed BU cases, by year of diagnosis.
(TIF)
S3 Fig. Selection of pseudoabsence points included in Buruli ulcer suitability models. Pseu-
doabsence points were selected outside of the BU surface range envelope (white; the area con-
taining values between the 2.5th and 97.5th percentile of all predictor variables) and selection
was biased according to the strength of evidence for BU at national or subnational level (yellow
to blue shading) using results from Simpson et al. Lancet Glob. Health 2019.
(TIF)
S4 Fig. Selection of pseudoabsence points included in Mycobacterium ulcerans suitability
models. Pseudoabsence points were selected outside of the MU surface range envelope (white;
the area containing values between the 2.5th and 97.5th percentile of all predictor variables)
and selection was biased according to the strength of evidence for BU and MU at national or
subnational level (yellow to blue shading) using results from Simpson et al. Lancet Glob.
Health 2019.
(TIF)
S5 Fig. Distribution of background points used in Buruli ulcer suitability models. Back-
ground points were restricted to a minimum distance of 10km from human occurrence points
(not shown on the map) and were selected with probability defined by the kernel density sur-
face representing the density of occurrence points.
(TIF)
S6 Fig. Distribution of background points used in Mycobacterium ulcerans suitability mod-
els. Background points were restricted to a minimum distance of 10km from human or envi-
ronmental occurrence points (not shown on the map) and were selected with probability
defined by the kernel density surface representing the density of occurrence points.
(TIF)
S7 Fig. Predicted environmental suitability for the occurrence of BU disease and associated
error of prediction, including all clinically diagnosed cases of BU.
(TIF)
S8 Fig. Individual model performance evaluation statistics for models of environmental
suitability for Buruli ulcer. Performance evaluated in terms of the mean true skill statistic
(TSS) and the mean area under the curve (AUC) of the receiver operation characteristic.
(TIF)
S9 Fig. Individual model performance evaluation statistics for models of environmental
suitability for Buruli ulcer. Performance evaluated in terms of accuracy (percent correctly
classified) and the mean area under the curve (AUC) of the receiver operation characteristic.
Individual model algorithms: ANN = artificial neural networks; GAM = generalized additive
models; GBM = generalized boosted regression models; GLM = generalized linear models;
MARS = multiple adaptive regression splines; MAXENT. Phillips = maximum entropy;
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RF = random forest.
(TIF)
S10 Fig. Variable importance plots of the contribution of environmental covariates to ran-
dom forest models of suitability. Shows contribution of variables to model for Buruli ulcer.
Blue bars = variables selected as predictors of BU occurrence and M. ulcerans in the environ-
ment. Orange bars = variables selected as predictors of Buruli ulcer (BU) occurrence only.
(TIF)
S11 Fig. Marginal effect plots showing the relationship between environmental covariates
and suitability for Buruli ulcer and Mycobacterium ulcerans in random forest models. Mar-
ginal Effect of Environmental Predictors on Environmental Suitability for Buruli ulcer
(TIF)
S12 Fig. Individual model performance evaluation statistics for models of environmental
suitability for Mycobacterium ulcerans. Performance evaluated in terms of the mean true
skill statistic (TSS) and the mean area under the curve (AUC) of the receiver operation charac-
teristic.
(TIF)
S13 Fig. Individual model performance evaluation statistics for models of environmental
suitability for Mycobacterium ulcerans. Performance evaluated in terms of accuracy (percent
correctly classified) and the mean area under the curve (AUC) of the receiver operation char-
acteristic. Individual model algorithms: ANN = artificial neural networks; GAM = generalized
additive models; GBM = generalized boosted regression models; GLM = generalized linear
models; MARS = multiple adaptive regression splines; MAXENT. Phillips = maximum
entropy; RF = random forest.
(TIF)
S14 Fig. Variable importance plots of the contribution of environmental covariates to ran-
dom forest models of suitability. Shows contribution of variables to model for Mycobacte-
rium ulcerans. Blue bars = variables selected as predictors of BU occurrence and M. ulcerans in
the environment Green bars = variables selected as predictors of M. ulcerans in the environ-
ment only
(TIF)
S15 Fig. Marginal effect plots showing the relationship between environmental covariates
and suitability for Buruli ulcer and Mycobacterium ulcerans in random forest models. Mar-
ginal Effect of Environmental Predictors on Environmental Suitability for Mycobacterium
ulcerans. Variables are plotted in order of their contribution to the random forest model. Mar-
ginal effect plots illustrate the effect of each explanatory variable on the outcome of suitability
for Buruli ulcer. Variables are plotted in order of their contribution to the random forest
model. �Interpretation of Enhanced Vegetation Index: low values (0.1–0.15) represent areas of
barren rock or sand and built-up land; moderate values (0.15–0.3.5) may indicate shrubs,
grassland or cropland; higher values (0.35–0.6) may indicate mixed wood and shrubs or open
forest.
(TIF)
S1 Table. Total area predicted suitable and population living in suitable areas for Buruli
ulcer, M. ulcerans, and both, by country in African continent. WM = weighted mean predic-
tion across final ensemble model; LB = lower bound of prediction; UB = upper bound of pre-
diction BU = Buruli Ulcer; MU = Mycobacterium ulcerans; CAR = Central African Republic;
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DRC = Democratic Republic of the Congo
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